Oligodendrocytes derive from progenitors (OPCs) through the interplay of epigenomic and transcriptional events. By integrating high-resolution methylomics, RNA-sequencing, and multiple transgenic lines, this study defines the role of DNMT1 in developmental myelination. We detected hypermethylation of genes related to cell cycle and neurogenesis during differentiation of OPCs, yet genetic ablation of Dnmt1 resulted in inefficient OPC expansion and severe hypomyelination associated with ataxia and tremors in mice. This phenotype was not caused by lineage switch or massive apoptosis but was characterized by a profound defect of differentiation associated with changes in exon-skipping and intron-retention splicing events and by the activation of an endoplasmic reticulum stress response. Therefore, loss of Dnmt1 in OPCs is not sufficient to induce a lineage switch but acts as an important determinant of the coordination between RNA splicing and protein synthesis necessary for myelin formation.
INTRODUCTION
Brain development requires the integration of cell-lineage selection and cell number regulation. This is achieved by coordinating cell proliferation with lineage identity. DNA methylation is a well-recognized epigenetic modification that is carefully regulated during cell division and guarantees faithful transmission of information to the daughter cells. This enzymatic activity is modulated by three proteins: DNMT1 (maintenance DNA methyltransferase, commonly associated with faithful transmission of genomic information from mother to daughter cells during cell division), DNMT3A, and DNMT3B (de novo methyltransferases methylating specific cytosines during development). The activity of these enzymes in the brain is higher than in any other adult tissue (Ono et al., 1993; Tawa et al., 1990) , highlighting the importance of DNMTs in neural development (Lister et al., 2013; Smith and Meissner, 2013) . This study addresses the role of DNA methylation in developmental myelination.
Genetic loss of Dnmt1 is lethal in mammals (Li et al., 1992 ) and zebrafish (Jacob et al., 2015) , because rapidly proliferating cells need to retain a stable epigenetic signature and are eliminated by apoptosis if compromised (Jackson-Grusby et al., 2001; Unterberger et al., 2006 ). An example is the apoptotic elimination of neural stem cells and mitotic neuroblasts lacking Dnmt1 (Fan et al., 2001; Hutnick et al., 2009; Milutinovic et al., 2003) . In contrast, inhibiting DNA methylation in astrocytes or Schwann cells is associated with precocious onset of differentiation, due to the unmasking of critical transcriptional regulatory sites in differentiation genes Takizawa et al., 2001 ; Varela-Rey et al., 2014) . In this study, we show that ablation of Dnmt1 in the oligodendrocyte (OL) lineage does not result in apoptosis or precocious myelination but causes the growth arrest of OL progenitors (OPCs) and a severely disrupted pattern of alternative splicing with the activation of an endoplasmic reticulum (ER) stress response, which precludes differentiation and results in severe and clinically symptomatic hypomyelination.
RESULTS
Dynamic DNA Methylation and DNA Methyltransferase Expression during OL Differentiation DNA methylation in proliferating progenitors has been shown to prevent untimely differentiation and to guarantee faithful transmission of genomic information from mother to daughter cells during replication Probst et al., 2009; Sen et al., 2010; Varela-Rey et al., 2014) . To begin characterizing the role of DNA methylation in OL-lineage cells, we quantified 5-methylcytosine (5-mC) in developing white matter tracts during embryonic and postnatal development. Quantification of the percentage of OLIG2+ OPCs expressing 5-mC ( Figure 1A ) revealed a greater proportion of highly methylated cells at late developmental time points ( Figure 1B) . A similar pattern was detected in cultured OPCs during differentiation into OLs (Figures 1C and 1D) . To further understand the role of DNA methylation in OPCs, we also evaluated the transcript (Figures 1E and 1F) and protein ( Figure 1G ) levels of the maintenance DNA methyltransferase Dnmt1 and the de novo methyltransferases Dnmt3a and Dnmt3b at two stages of development. While Dnmt1 levels decreased with differentiation, Dnmt3a levels did not significantly change, and Dnmt3b levels were undetectable at either stage (data not shown).
To generate a genome-wide map of the DNA methylation landscape during the transition from OPC to OL, we used fluorescence-activated cell sorting (FACS) of the brains from transgenic mice expressing GFP driven by OL-lineage-specific promoters at postnatal day (P)2 (Pdgfra-GFP) and P18 (Plp1-GFP) (Figure 2A) . We previously characterized the Pdgfra-GFP sorted OPC as expressing progenitor markers (e.g., Cspg4 and Pdgfra) and not expressing myelin genes (e.g., Mog and Mag), while Plp1-GFP sorted OLs were characterized by the expression of differentiation genes and the absence of progenitor markers (Moyon et al., 2015) . DNA methylation mapping was performed by enhanced reduced representation bisulfite sequencing (ERRBS), which combined restriction enzyme digestion (i.e., MspI) of genomic DNA with bisulfite sequencing and provided single-base resolution and highly quantitative data on the methylation state of cytosines throughout the genome. The mean coverage was 1.47 million individual CpGs in the mouse genome (Table S1) , with the majority detected at gene promoters ( Figure S1C ). Among those, we identified 62,807 differentially methylated CpGs as OPCs differentiated (q value <0.01) with 29,707 hypomethylated and 33,100 hypermethylated CpGs. Regions containing at least two CpGs with a minimum difference of 10% between the two stages of differentiation were classified as differentially methylated regions (DMRs). This revealed the clustering of CpGs into 7,386 DMRs characterizing the differentiation of OPC, with 2,385 hypermethylated regions (with an average methylation difference of 22.2% ± 8.5%) ( Figure S1B ). Biological replicates confirmed the reproducibility of the methylation state (Pearson's r > 0.9), while comparisons of DMRs in samples obtained at the two developmental time points displayed great disparity ( Figure S1A ), further supporting the large shift in the DNA methylome during differentiation. To determine the relationship between DNA methylation and transcription, we performed RNA sequencing (RNA-seq) on the same FACS-isolated populations ( Figure 2 ; Table S2 ). Separate clustering of the samples isolated at distinct time points and differential expression of stage-specific markers (Pdgfra: fold change, À8.2; q value = 5.5 3 10
À220
; Cspg4: fold change, À7.0; q value = 4.5 3 10 À169 ; Plp1: fold change, 2.3; q value = 6.4 3 10 À3 ; Mog: fold change, 4.9; q value = 2.09 3 10 À34 ; Mag: fold change, 2.4; q value = 2.6 3 10
À26
) between the two populations confirmed the selectivity of our cell sorting ( Figure S2A ). The analysis revealed 3,204 upregulated (average fold change = 3.6 ± 1.8) and 3,547 downregulated transcripts (average fold change = 5.6 ± 2.4) during differentiation. Upregulated genes included gene ontology (GO) categories related to lipid metabolism and axon ensheathment, while downregulated categories included cell cycle, cell migration, and neuronal differentiation ( Figures S2B and S2C ). The overwhelming overlap (p < 10 À244 )
of our dataset and the published in vitro RNA-seq study further strengthened the validity of our analysis ( Figure S2D ). To characterize the transcriptional consequences of genomewide distribution of DNA methylation, we overlapped the differential transcript expression with DNA methylation differences at promoters and represented the analysis as quadrant plot, based on statistical power ( Figure 2B ). The most statistically significant differences (based on number of events and difference at the two developmental stages) were identified in two quadrants (I and IV). The highest significance was detected in quadrant IV (p = 8.1 3 10 À19 ), which defined hypermethylated genes with decreased expression during differentiation and included genes related to neuronal lineage (e.g., Pax6, Plxnb2, Camk1, and Ephb2) and proliferation (e.g., Cdc6 and Meis2) (Figures 2D and 2F) . Quadrant I was also significant (p = 2.5 3 10 À7 ) and included hypomethylated genes with increased expression during differentiation, such as lipid enzymes, myelin components (e.g., Mog and Mag), and enzymes enriched in the myelin compartment such as carbonic anhydrase II (Car2), as well as molecules associated with the differentiated state such as the G-protein-coupled receptor 37 (Gpr37) ( Figures 2C and 2E ). The other two quadrants (hypomethylated genes with decreased expression or hypermethylated genes with increased expression during differentiation) did not reach statistical significance and, therefore, were not pursued any further. Taken together, these data highlight the relevance of DNA methylation in OPCs for silencing genes related to cell proliferation and neuronal lineage. Figure 3A ) or DNMT3A ( Figure 3B ) and those specific for cell markers. Figure 3D ). only minor differences in body size ( Figure 3E ) but clear signs of hypomyelination of the spinal cord (see Figure 3F , translucent spinal cord) and brain stem ( Figure 3G ), which were confirmed by electron microscopy ( Figures 3H and S3 ).
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The Hypomyelinated Phenotype Detected in Dnmt1
Mutants Is Not Attributable to Fate-Lineage Switch Given the early activity of Olig1-cre at the pMN domain (Zhou and Anderson, 2002) and based on the detection of increased methylation and silencing of neuronal lineage-related genes during OPC differentiation, it was important to determine whether the defective myelination phenotype detected in Olig1 cre/+ ; Dnmt1 fl/fl mice could be attributed to impaired specification. To address this question, we used two approaches. First, we processed spinal cord sections from mutants and control siblings at embryonic day (E)12.5 for immunohistochemistry using antibodies specific for motor neurons (i.e., MNX1), as well as ventral (i.e., NKX2.2) and dorsal (i.e., PAX6) markers. Quantification of immunoreactive cells revealed no differences in the number of OLIG2+ at the pMN domain or of MNX1+ at the ventrolateral motor neuron domain (Figures 4A and 4B) . The distribution and number of NKX2.2+ ( Figure 4C ) and PAX6+ cells ( Figure 4D ) were similar in mice of the two genotypes, and the boundaries with the OLIG2+ domain were preserved. We then conducted a fate-mapping analysis crossing the ROSA26-loxSTOP-lox-TdTomato reporter line with the Olig1
cre/+ ;Dnmt1 +/+ mice and stained spinal cord sections at P14 with neuronal (NeuN) or astrocytic (GFAP) markers (Figures 4E and 4F) . Only very few cells were identified by the reporter expression and staining for NeuN or GFAP, both in controls and mutants (NeuN controls = 2.5% ± 0.3%, mutants = 3.2% ± 1.0%; GFAP controls = 3.0% ± 0.4%, mutants = 3.7% ± 0.6%), suggesting that only very few OPCs differentiated in neurons or astrocytes in the absence of Dnmt1.
Dnmt1-Dependent Hypomyelination as a Result of Defective Differentiation
To define the potential cause of the hypomyelinating phenotype, we conducted a quantitative immunohistochemical study of the developing spinal cord from E16.5 to P16 using antibodies (legend continued on next page) specific for OLIG2 and platelet-derived growth factor receptor a (PDGFRa) to label OPCs, CC1 to label newly generated OLs, and MBP to label myelinating cells. While a similar number of progenitors was detected in the embryonic spinal cord, a 27% reduction in the number of OPCs was detected in the mutant spinal cords ( Figure 5A ) and brains ( Figure S4A ), starting from P2. A greater reduction was observed for newly generated OLs (Figures 5B and S4B) , and an even more dramatic impairment was detected when quantifying myelinating MBP+ cells ( Figures 5C and S4C ), which represent a later stage of differentiation. The cell-autonomous nature of this defect was further validated in vitro, which revealed defective differentiation of mutant OPCs compared to controls ( Figure 5D ). Together, these data support the critical importance of DNMT1 in the OL lineage to coordinate the late stages of differentiation into myelin-forming cells.
To begin understanding the mechanisms underlying the very modest decrease in progenitor numbers and the almost complete absence of myelin detected by electron microscopy, we processed spinal cord sections from controls and mutants at multiple developmental time points for TUNEL (data not shown) or for the presence of active cleaved caspase-3. An accurate assessment of apoptotic nuclei is difficult in vivo, due to rapid clearance, and despite the detection toward modestly increased apoptosis at P9, the measurable differences did not reach statistical significance ( Figure 6A ). An alternative explanation for the reduced OPC number was impaired proliferation. Co-labeling of OPCs with antibodies specific for OLIG2 or PDGFRa and markers of proliferation (i.e., Ki67) or of mitotic activity (i.e., phosphorylated histone H3) ( Figures 6B and 6D ) identified a clear proliferation defect in mutants. This result was cell intrinsic, as it was also detected in cultured OPCs (Figures 6C and 6E) . We concluded that the lower number of OPCs in the developing spinal cord of mutant mice compared to that of age-matched controls could, at least in part, be attributed to defective expansion of the progenitor pool in the absence of Dnmt1. Since this phenotype was associated with the detection of concurrent hypomethylation and increased transcripts for genes modulating mitosis (e.g., Meis2 and Cdc6), together with those inhibiting the cell cycle (e.g., Cdkn1a), and with the downregulation of positive regulators of proliferation (e.g., Pdgfra, Rbl2, and Mcm7) (Figures 6F and 6G) , we reasoned that OPCs might have activated strategies to counteract the consequences of Dnmt1 ablation after escaping apoptosis. The transcriptional changes leading to opposing effects on proliferation suggested the potential activation of a genotoxic response, possibly resulting in growth arrest. This was validated by the detection of phosphorylated H2AX immunoreactivity, a histone mark demarcating regions of chromatin with double-stranded DNA (dsDNA) breaks (Unterberger et al., 2006) , both in vivo ( Figure 6H ) and in vitro ( Figure 6I ). Figure S5A ; Table S3 ). Loss of Dnmt1 resulted in 994 downregulated and 566 upregulated genes in mutant cells, compared to controls (Tables S4 and S5 ). Downregulated genes included myelin genes, OL-specific factors, and lipid metabolism enzymes (Figure S3B ), which were further validated by qPCR ( Figure S3D ). Upregulated gene categories included cell division and response to DNA stress ( Figures 6G and S3C) . Consistent with the detection of normal lineage specification, we did not detect any upregulation of neuronally enriched gene categories. Because OL differentiation is characterized by alternatively spliced events (Kevelam et al., 2015; Nave et al., 1987) , we interrogated our RNA-seq dataset in control and mutant cells ( Figure 7A ). It has been suggested that DNA methylation in specific genomic regions is critical for exon skipping and intron retention splicing events (Gelfman et al., 2013; Yearim et al., 2015) . Consistent with these data, we detected severe impairment of exon skipping and intron retention splicing in mutant OPC (Olig1 cre/+ ; Dnmt1 fl/fl ;Pdgfra-GFP) compared to wild-type ( Figure 7B ). These events occurred in GO categories identified as: myelination, lipid metabolism and cell cycle ( Figure 7C ). An example of splicing defects associated with defective DNA methylation is shown for the gene Mcm7, a ubiquitously expressed cell cycle gene characterized by intron retention ( Figure 7D ). Hypermethylated CpGs in wild-type OPC within the spliced regions were associated with intron splicing while hypomethylated CpGs in mutant cells were associated with intron-retention ( Figure 7E ). Together, these data provided molecular validation of the relationship between aberrant DNA methylation and alternatively spliced defect, as suggested by the RNA-seq analysis. It is likely that aberrant splicing might change protein conformation (Kevelam et al., 2015; Yura et al., 2006) and lead to the potential accumulation of incorrectly folded proteins inducing ER stress. Consistent with this possibility, we observed dilated ERs in mutant OLs, with characteristic and unique electrondense inclusions ( Figure 7F ), suggestive of protein accumulations and activation of ER stress response. This interpretation was further supported by the detection of specific downstream targets of ER response pathways in mutant mice, including Bip (downstream of ATF6), Chop (downstream of PERK), and spliced Xbp1 (downstream of the IRE1 pathway) ( Figure 7G) See also Figure S3 and Movie S1.
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did not induce any change ( Figure 7H ). These results suggested that Dnmt1 ablation in OPCs resulted in inappropriate protein folding, likely as a result of the dramatic changes in alternative splicing events detected in mutants. Overall, this study supports a role for DNA methylation in OL differentiation that goes beyond the repression of progenitor stage genes and includes the regulation of alternative splicing events at later stages of differentiation, which are critical for the attainment of the myelinating phenotype.
DISCUSSION
OPCs are the last cells to differentiate in the developing CNS, and their maturation is characterized by the silencing of alternative lineages and genome-wide deposition of repressive histone K9 and K27 methylation marks (Liu et al., 2015; Sher et al., 2008 Sher et al., , 2012 . Our genome-wide analysis of differentially methylated genes during the differentiation of OPCs into OLs directly sorted from developing brains revealed hypermethylation at the promoter of OPC-specific genes in response to mitogens (such as Pdgfra), as well as regulators of DNA replication (such as Cdc6), and neuronal-lineage genes (such as Pax6). This suggested that DNA methylation contributes to the transition of OPCs to OLs by regulating cell-cycle exit and, possibly, lineage choice decisions. The concept of fine-tuning of the DNA methylome during mammalian brain development was previously suggested (Kessler et al., 2016; Lister et al., 2013) , and we had predicted two potential outcomes to the ablation of Dnmts in OPCs: increased OPC proliferation and potential lineage-choice switch. In neural stem cells, Dnmt1 ablation led to decreased survival and astroglial differentiation (Fan et al., 2001) ; in astrocytes, it led to precocious differentiation He et al., 2005) .
Interestingly, none of the predicted outcomes was observed in mice with Dnmt1 ablation in the OL lineage. Despite the hypomethylation of myelin genes, OPCs did not undergo precocious differentiation. Given the relationship between cell-cycle exit and differentiation (Magri et al., 2014) , a potential explanation for the mouse phenotype was the possible retention of OPCs in a proliferative state, which was suggested by the hypomethylation of genes regulating DNA replication (e.g., Meis2 and Cdc6). However, mutant OPCs exited from the cell cycle and inefficiently differentiated, despite the removal of the ''methylation brake'' on the promoter of myelin genes. Reduced OPC proliferation was associated with the detection of phoshorylated histone H2AX, a measure of genotoxic stress (Albino et al., 2009; Lawless et al., 2010) . This was consistent with the idea that DNMT1 plays a critical role in the fidelity of transmission of (legend continued on next page) epigenetic information from mother to daughter cells during cell division (Fan et al., 2001; Probst et al., 2009; Sen et al., 2010) . In its absence, specific ''sensors'' induce dsDNA breaks and activate specific kinases that, in turn, phosphorylate the nucleosomal histones and mark these regions as ''damaged'' (Altaf et al., 2007; Mé ndez-Acuñ a et al., 2010; Rossetto et al., 2012) . This initiates a response resulting in growth arrest or apoptosis, in an attempt to contain the number of cells with aberrant information (Milutinovic et al., 2003; Unterberger et al., 2006) . In contrast to other cell types (Fan et al., 2001; Jacob et al., 2015) , OPCs lacking Dnmt1 did not display massive apoptosis, and we reasoned that this was likely due to the fact that OPCs are the last cells to differentiate at the tail end of development, when all the other organs and systems are already in place, and altered DNA methylation in these cells may not represent an immediate threat to the overall health of the organism.
After exiting from the cell cycle, OPCs only inefficiently differentiated into OLs and they were unable to generate large amounts of myelin components, thereby resulting in a severely hypomyelinated phenotype, which could not be explained simply in terms of cell number reduction. We also did not detect increased expression of neuronal or astrocytic genes, indicative of a potential lineage switch. This was consistent with the results of fate-mapping experiments and highlighted the reliance of lineage choices on multiple modalities of repression requiring the concerted cooperation of DNA methylation and repressive histone methylation marks occurring during OL differentiation (Liu et al., 2015) .
At the ultrastructural level, the preservation of axonal diameter in mutants, despite the absence of myelin suggested, at least in part, the preservation of signaling between OLs and axons. However, the detection of enlarged ER cisternae and electron-dense inclusion bodies in mutant OLs was reminiscent of proteinaceous aggregates reported in other cell types (Ronzoni et al., 2010; Valetti et al., 1991) and suggested the activation of an ER stress response. A detailed molecular analysis of the three ER response pathways identified the sequential activation of the ATF6 and PERK pathways prior to the engagement of the IRE1 response (Hetz et al., 2013; Oslowski and Urano, 2011) , validating the results of the ultrastructural data. A potential explanation for the activation of the ER stress response in oligodendroglial cells lacking Dnmt1 was suggested by RNA sequencing analysis that revealed a massive alteration of alternative splicing. Our analysis identified defective exon-skipping and intron-retention events in mutant cells, while other modalities of splicing, including alternative exons and 5 0 or 3 0 acceptor sites were not affected. It has been previously reported that differential methylation of CpGs in specific genomic areas results in defective splicing (Gelfman et al., 2013; Hnilicová and Stan ek, 2011; Iannone and Valcá rcel, 2013) , and our study provides an in vivo validation, in the CNS, for this proposed model. We validated the co-occurrence of differential DNA methylation and altered retained-intron splicing in selected genes, supporting the concept that DNA methylation is tightly linked to this form of splicing events, and its absence results in a wide rearrangement of RNA-splicing events, which, in turn, may cause aberrant protein folding, possibly leading to the activation of an ER stress response.
We conclude that the role of DNMT1 in OL-lineage cells is more complex than originally anticipated and encompasses the regulation of the proliferative state of OPC, as well as a tight coordination between alternative splicing and protein synthesis in the generation of myelinating OLs.
EXPERIMENTAL PROCEDURES Animals
All experiments were conducted according to the Icahn School of Medicine at Mount Sinai institutional animal care and use committee (IACUC)-approved protocols. Dnmt1 fl/fl (Fan et al., 2001; Jackson-Grusby et al., 2001) and fl/fl ;Pdgfra-GFP brains (Klinghoffer et al., 2002) and OLs from P18 Plp1-GFP brains (Spassky et al., 1998) using FACS as described previously (Moyon et al., 2015) .
DNA Methylation Analysis
ERRBS libraries were prepared from 50 ng input DNA per biological replicate following a modified (Akalin et al., 2012) protocol (Gu et al., 2011) and sequenced using the Illumina HiSeq 2000 instrument. DMRs were selected at a q value <0.05 and with a minimum mean difference of 10% per region. DMRs were independently validated using MassARRAY EpiTYPER assays (Sequenom), as previously described (Huynh et al., 2014) . Genomic DNA was sodium bisulfite treated using an EpiTect Bisulfite Kit (QIAGEN). See details and primers in the Supplemental Information.
Gene Expression Analysis
Approximately 250 ng of total RNA per sample was used for library construction with the TruSeq RNA Sample Prep Kit (Illumina) and sequenced using the Illumina HiSeq 2000 and the Illumina HiSeq 2500 instruments according to the manufacturer's instructions for 50-bp (OPC-OL) or 100-bp (Dnmt1cKO) paired-end read runs. High-quality reads were aligned to the mouse reference genome (mm10), RefSeq exons, splicing junctions, and contamination databases (ribosome and mitochondria sequences) using the Burrows-Wheeler Aligner (BWA) algorithm. The read count for each RefSeq transcript was extracted using uniquely aligned reads to exon and splice-junction regions. The raw read counts were input into DESeq2 v1.2.5 (Anders and Huber, 2010) to normalize the signal for each transcript and to ascertain differential gene expression with associated q values. Differentially expressed genes were selected at a p value <0.05 and q value <0.01 with a fold change >2 for the OPC-OL comparison only. To identify enriched gene functions, we computed hypergeometric p values for over-representation of each biological process GO category using GOrilla (Eden et al., 2009 ). For genome-wide annotation, org.Mm.eg.db was used in the GOstats R package (Falcon and Gentleman, 2007 Data indicate mean ± SEM. *p < 0.05, **p < 0.01; ***p < 0.005 (ANOVA). See also Figure S5 .
exon (MXE), and retained intron (RI). Spliced events between two conditions were defined by a p value <0.05. Additional details are given in the Supplemental Information.
Electron Microscopy and Immunohistochemistry
For electron microscopy, mice were deeply anesthetized and transcardially perfused with 0.9% NaCl, followed by 0.1 M Millonig's solution containing 4% paraformaldehyde and 5% glutaraldehyde (pH 7.3), followed by 2 weeks of post-fixation in the same fixative solution at 4 C, as previously described (He et al., 2007) . For immunohistochemistry, animals were perfused with 4% paraformaldehyde and post-fixed overnight in the same solution at 4 C. Tissue samples were then transferred to 70%
ethanol, sequentially dehydrated, and embedded in paraffin. Immunohistochemistry was performed in 4-to 10-mm sections. All images were acquired using a Zeiss Observer A1 fluorescent microscope or a Zeiss LSM780 upright confocal microscope. Quantification was carried out using ImageJ on two to three sections per mouse and three to four mice for each age and genotype.
Primary OPC Cultures
Mouse OPCs were isolated from P7 mice as described previously (Cahoy et al., 2008) , plated in 24-well dishes and kept proliferating in platelet-derived growth factor (PDGF)-AA (10 ng/ml) and basic fibroblast growth factor (bFGF) (20 ng/ml) or differentiated with T3 hormone (45 nM).
Rat primary glial cells were generated from 2-to 3-day-old Sprague-Dawley rats (Harlan UK), according to published procedures.
Statistical Methods
A minimum of three replicates per group was used for each experiment. Unpaired Student's t test was used for cell counts and transcript levels for every two datasets following a normal distribution. A two-way ANOVA was used to compare three or more sets of data, including cell counts and MassARRAY data. For all graphs, error bars indicate mean ± SEM.
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